We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » AVENTIS TO FILE REPORT WITH FDA OVER DRUG DEATHS IN JAPAN
The item has been added to your shopping cart.
AVENTIS TO FILE REPORT WITH FDA OVER DRUG DEATHS IN JAPAN
January 30, 2004
Faced with a barrage of international news stories, Aventis said last week it would file a report with the FDA about the deaths of five Japanese patients participating in a postmarketing study of its rheumatoid arthritis drug Arava, although the company contends there is no clear evidence the drug caused the fatalities.